Issue №087 · 2026-08-09

Daily Briefing · 2026-08-09

Physicians

Ensoma sheds more staff, pauses preclinical programs to home in on lead gene therapy

  • Boston biotech Ensoma is doubling down on its lead gene therapy for a rare immune disease, laying off another round of employees after previously halving its workforce last November.
FierceBiotech ↗
Nursing

Industry Voices—AI won’t fix nurse burnout. Nurses will

  • If AI rollouts follow the path of the technologies that came before them—designed for the system, not the people inside it—they could deepen the very burnout they’re trying to relieve.
Fierce Healthcare ↗
Health OS

Weekly Rundown: Hers rolls out new AI-native app; Novo Nordisk, H1 partner on AI-driven clinical development

  • The latest news from Hims & Hers, Atropos Health, Signal 1, NewYork-Presbyterian, Sharecare, Novo Nordisk, H1, Strida, Hackensack Meridian Health and ModMed.
Fierce Healthcare ↗

← All issues

Smillin.

A daily 5-minute brief on AI, devices, and digital tools across physicians, dentistry, pharmacy, physician assistants, nursing, digital health, and Health OS. Read by clinicians.

Smillin

Connect

© 2026 Smillin Healthcare TechTermsPrivacyUSA · Daily 6 AM ET